{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:53:40Z","timestamp":1794110020156,"version":"4.8.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2024YFC2310601"],"award-info":[{"award-number":["2024YFC2310601"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473313"],"award-info":[{"award-number":["82473313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Xiamen Industry-Academia-Research Projects","award":["2024CXY0113"],"award-info":[{"award-number":["2024CXY0113"]}]},{"name":"Xiang An Innovation Laboratory Science and Technology Plan Project","award":["2023XAKJ0101019"],"award-info":[{"award-number":["2023XAKJ0101019"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["20720220004"],"award-info":[{"award-number":["20720220004"]}]},{"name":"the Natural Science Foundation of Fujian Province, China","award":["2022J02005"],"award-info":[{"award-number":["2022J02005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03560-2","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:00:44Z","timestamp":1751364044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Novel adjuvant delivery system constructed by alum-emulsion hybrid nanoparticles with TLR9 agonists boosts vaccine immunity"],"prefix":"10.1186","volume":"23","author":[{"given":"Yarong","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciying","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"11","key":"3560_CR1","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/d41573-023-00119-4","volume":"22","author":"J Yue","year":"2023","unstructured":"Yue J, Liu Y, Zhao M, Bi X, Li G, Liang W. The R&D landscape for infectious disease vaccines. Nat Rev Drug Discov. 2023;22(11):867\u20138.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"3560_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/cmdc.201200487","volume":"8","author":"PM Moyle","year":"2013","unstructured":"Moyle PM, Toth I. Modern subunit vaccines: development, components, and research opportunities. ChemMedChem. 2013;8(3):360\u201376.","journal-title":"ChemMedChem"},{"issue":"2","key":"3560_CR3","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3390\/ijms24021701","volume":"24","author":"A Kovalenko","year":"2023","unstructured":"Kovalenko A, Ryabchevskaya E, Evtushenko E, Nikitin N, Karpova O. Recombinant protein vaccines against human betacoronaviruses: strategies, approaches and progress. Int J Mol Sci. 2023;24(2):1701.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3560_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s40121-024-00945-y","volume":"13","author":"R Han","year":"2024","unstructured":"Han R, San Martin P, Ahmed N, Guzman-Holst A, Mohy A, Pinto T, de Veras B, Gomez JA, Bibera GL, van Oorschot DAM. Modelling the public health burden of herpes Zoster and the impact of adjuvanted Recombinant Zoster vaccine in five selected countries in Southeast Asia. Infect Dis Ther. 2024;13(4):761\u201378.","journal-title":"Infect Dis Ther"},{"issue":"10","key":"3560_CR5","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S1473-3099(18)30292-5","volume":"18","author":"NI Mazur","year":"2018","unstructured":"Mazur NI, Higgins D, Nunes MC, Melero JA, et al. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. Lancet Infect Dis. 2018;18(10):e295\u2013311.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"3560_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s13346-021-00924-7","volume":"11","author":"C D\u2019Amico","year":"2021","unstructured":"D\u2019Amico C, Fontana F, Cheng R, Santos HA. Development of vaccine formulations: past, present, and future. Drug Deliv Transl Res. 2021;11(2):353\u201372.","journal-title":"Drug Deliv Transl Res"},{"issue":"6","key":"3560_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","volume":"20","author":"B Pulendran","year":"2021","unstructured":"Pulendran B, S, Arunachalam P, O\u2019Hagan DT. Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov. 2021;20(6):454\u201375.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"3560_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2105\/AJPH.22.1.7","volume":"22","author":"WH Park","year":"1932","unstructured":"Park WH, Schroder MC. Diphtheria Toxin-Antitoxin and toxoid. Am J Public Health Nations Health. 1932;22(1):7\u201316.","journal-title":"Am J Public Health Nations Health"},{"key":"3560_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00705-010-0863-1","volume":"156","author":"PMH Heegaard","year":"2010","unstructured":"Heegaard PMH, Dedieu L, Johnson N, Le Potier M-F, Mockey M, Mutinelli F, Vahlenkamp T, Vascellari M, S\u00f8rensen NS. Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. Arch Virol. 2010;156:183\u2013202.","journal-title":"Arch Virol"},{"issue":"2","key":"3560_CR10","first-page":"290","volume":"183","author":"A Iwasaki","year":"2020","unstructured":"Iwasaki A, Omer SB. Why How Vaccines Work Cell. 2020;183(2):290\u20135.","journal-title":"Why How Vaccines Work Cell"},{"issue":"10","key":"3560_CR11","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","volume":"183","author":"AM Didierlaurent","year":"2009","unstructured":"Didierlaurent AM, Morel S, Lockman L, et al. AS04, an aluminum Salt- and TLR4 Agonist-Based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol. 2009;183(10):6186\u201397.","journal-title":"J Immunol"},{"issue":"32","key":"3560_CR12","doi-asserted-by":"publisher","first-page":"13448","DOI":"10.1021\/ja305121q","volume":"134","author":"EK Chea","year":"2012","unstructured":"Chea EK, Fern\u00e1ndez-Tejada A, Damani P, Adams MM, Gardner JR, Livingston PO, Ragupathi G, Gin DY. Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probes. J Am Chem Soc. 2012;134(32):13448\u201357.","journal-title":"J Am Chem Soc"},{"issue":"12","key":"3560_CR13","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s40266-018-0603-x","volume":"35","author":"YY Syed","year":"2018","unstructured":"Syed YY. Recombinant Zoster vaccine (Shingrix\u00ae): A review in herpes Zoster. Drugs Aging. 2018;35(12):1031\u201340.","journal-title":"Drugs Aging"},{"issue":"7","key":"3560_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrmicro1681","volume":"5","author":"B Guy","year":"2007","unstructured":"Guy B. The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol. 2007;5(7):505\u201317.","journal-title":"Nat Rev Microbiol"},{"key":"3560_CR15","doi-asserted-by":"crossref","unstructured":"Zeng Y, Zou F, Xia N, Li S. In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives. Expert Rev Vaccines. 2023 Jan-Dec;22(1):681\u201395.","DOI":"10.1080\/14760584.2023.2238807"},{"key":"3560_CR16","doi-asserted-by":"publisher","first-page":"1043109","DOI":"10.3389\/fimmu.2023.1043109","volume":"14","author":"SK Verma","year":"2023","unstructured":"Verma SK, Mahajan P, Singh NK, Gupta A, Aggarwal R, Rappuoli R, Johri AK. New-age vaccine adjuvants, their development, and future perspective. Front Immunol. 2023;14:1043109.","journal-title":"Front Immunol"},{"issue":"1","key":"3560_CR17","first-page":"1","volume":"20","author":"A Habib","year":"2023","unstructured":"Habib A, Anjum KM, Iqbal R, Jaffar G, Ashraf Z, Khalid MS, Taj MU, Zainab SW, Umair M, Zohaib M, Khalid T. Vaccine adjuvants: selection criteria, mechanism of action associated with immune responses and future directions. Iran J Immunol. 2023;20(1):1\u201315.","journal-title":"Iran J Immunol"},{"issue":"1","key":"3560_CR18","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","volume":"28","author":"Y Su","year":"2021","unstructured":"Su Y, Zhang B, Sun R, Liu W, Zhu Q, Zhang X, Wang R, Chen C. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Deliv. 2021;28(1):1397\u2013418.","journal-title":"Drug Deliv"},{"issue":"4","key":"3560_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/pharmaceutics13040455","volume":"13","author":"KC Petkar","year":"2021","unstructured":"Petkar KC, Patil SM, Chavhan SS, Kaneko K, Sawant KK, Kunda NK, Saleem IY. An overview of Nanocarrier-Based adjuvants for vaccine delivery. Pharmaceutics. 2021;13(4):455.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3560_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/vaccines8010128","volume":"8","author":"ZB Wang","year":"2020","unstructured":"Wang ZB, Xu J. Better adjuvants for better vaccines: progress in adjuvant delivery systems, modifications, and adjuvant-Antigen codelivery. Vaccines (Basel). 2020;8(1):128.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"3560_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1586\/erv.12.140","volume":"12","author":"DT O\u2019Hagan","year":"2013","unstructured":"O\u2019Hagan DT, Ott GS, Van Nest G, et al. The history of MF59\u00ae adjuvant: A phoenix that arose from the ashes. Expert Rev Vaccines. 2013;12(1):13\u201330.","journal-title":"Expert Rev Vaccines"},{"key":"3560_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jconrel.2013.10.032","volume":"173","author":"X Li","year":"2014","unstructured":"Li X, Aldayel AM, Cui Z. Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles. J Control Release. 2014;173:148\u201357.","journal-title":"J Control Release"},{"key":"3560_CR23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jconrel.2019.07.003","volume":"309","author":"C Albert","year":"2019","unstructured":"Albert C, Beladjine M, Tsapis N, Fattal E, Agnely F, Huang N. Pickering emulsions: Preparation processes, key parameters governing their properties and potential for pharmaceutical applications. J Control Release. 2019;309:302\u201332.","journal-title":"J Control Release"},{"key":"3560_CR24","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/IJN.S36111","volume":"7","author":"E Fr\u00f6hlich","year":"2012","unstructured":"Fr\u00f6hlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed. 2012;7:5577\u201391.","journal-title":"Int J Nanomed"},{"key":"3560_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40005-020-00504-w","volume":"51","author":"TM Kiio","year":"2021","unstructured":"Kiio TM, Park S. Physical properties of nanoparticles do matter. J Pharm Investig. 2021;51:35\u201351.","journal-title":"J Pharm Investig"},{"key":"3560_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jconrel.2024.12.044","volume":"378","author":"W Zhang","year":"2025","unstructured":"Zhang W, Cui H, Xu J, Shi M, Bian L, Cui L, Jiang C, Zhang Y. Biodistribution and mechanisms of action of MF59 and MF59-like adjuvants. J Control Release. 2025;378:573\u201387.","journal-title":"J Control Release"},{"issue":"Pt 2","key":"3560_CR27","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.msec.2016.03.045","volume":"70","author":"H Zhang","year":"2017","unstructured":"Zhang H, Gao XD. Nanodelivery systems for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides. Mater Sci Eng C Mater Biol Appl. 2017;70(Pt 2):935\u201346.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"4","key":"3560_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1586\/erv.10.174","volume":"10","author":"C Bode","year":"2011","unstructured":"Bode C, Zhao G, Steinhagen F, et al. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines. 2011;10(4):499\u2013511.","journal-title":"Expert Rev Vaccines"},{"issue":"9\u201310","key":"3560_CR29","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.vaccine.2003.09.037","volume":"22","author":"A Wittayanukulluk","year":"2004","unstructured":"Wittayanukulluk A, Jiang D, Regnier FE, Hem SL. Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen. Vaccine. 2004;22(9\u201310):1172\u20136.","journal-title":"Vaccine"},{"issue":"2","key":"3560_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nmat5057","volume":"17","author":"Y Xia","year":"2018","unstructured":"Xia Y, Wu J, Wei W, Du Y, Wan T, Ma X, An W, Guo A, Miao C, Yue H, Li S, Cao X, Su Z, Ma G. Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination. Nat Mater. 2018;17(2):187\u201394.","journal-title":"Nat Mater"},{"issue":"45","key":"3560_CR31","doi-asserted-by":"publisher","first-page":"13379","DOI":"10.1021\/acs.langmuir.1c02056","volume":"37","author":"DJ Pochapski","year":"2021","unstructured":"Pochapski DJ, Carvalho Dos Santos C, Leite GW, Pulcinelli SH, Santilli CV. Zeta potential and colloidal stability predictions for inorganic nanoparticle dispersions: effects of experimental conditions and electrokinetic models on the interpretation of results. Langmuir. 2021;37(45):13379\u201389.","journal-title":"Langmuir"},{"key":"3560_CR32","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.cis.2020.102344","volume":"288","author":"F Ravera","year":"2021","unstructured":"Ravera F, Dziza K, Santini E, Cristofolini L, Liggieri L. Emulsification and emulsion stability: the role of the interfacial properties. Adv Colloid Interface Sci. 2021;288:102344.","journal-title":"Adv Colloid Interface Sci"},{"issue":"3","key":"3560_CR33","doi-asserted-by":"publisher","first-page":"e13192","DOI":"10.1111\/cpr.13192","volume":"55","author":"Y Shen","year":"2022","unstructured":"Shen Y, Guo D, Ji X, Zhou Y, Liu S, Huang J, Song H. Homotypic targeting of Immunomodulatory nanoparticles for enhanced peripheral and central immunity. Cell Prolif. 2022;55(3):e13192.","journal-title":"Cell Prolif"},{"issue":"1","key":"3560_CR34","doi-asserted-by":"publisher","first-page":"11520","DOI":"10.1038\/s41598-019-47885-z","volume":"9","author":"RR Shah","year":"2019","unstructured":"Shah RR, Taccone M, Monaci E, Brito LA, Bonci A, O\u2019Hagan DT, Amiji MM, Seubert A. The droplet size of emulsion adjuvants has significant impact on their potency, due to differences in immune cell-recruitment and -activation. Sci Rep. 2019;9(1):11520.","journal-title":"Sci Rep"},{"issue":"14","key":"3560_CR35","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.vaccine.2019.02.033","volume":"37","author":"F Lu","year":"2019","unstructured":"Lu F, Mosley YYC, Carmichael B, et al. Formulation of aluminum hydroxide adjuvant with TLR agonists poly(I:C) and CpG enhances the magnitude and avidity of the humoral immune response. Vaccine. 2019;37(14):1945\u201353.","journal-title":"Vaccine"},{"issue":"45","key":"3560_CR36","doi-asserted-by":"publisher","first-page":"50592","DOI":"10.1021\/acsami.2c15644","volume":"14","author":"D Qiao","year":"2022","unstructured":"Qiao D, Li L, Liu L, Chen Y. Universal and translational nanoparticulate CpG adjuvant. ACS Appl Mater Interfaces. 2022;14(45):50592\u2013600.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"32","key":"3560_CR37","doi-asserted-by":"publisher","first-page":"e2301687","DOI":"10.1002\/adhm.202301687","volume":"12","author":"Z Zhong","year":"2023","unstructured":"Zhong Z, Chen Y, Deswarte K, Lauwers H, De Lombaerde E, Cui X, Van Herck S, Ye T, Gontsarik M, Lienenklaus S, Sanders NN, Lambrecht BN, De Koker S, De Geest BG. Lipid nanoparticle delivery alters the adjuvanticity of the TLR9 agonist CpG by innate immune activation in lymphoid tissue. Adv Healthc Mater. 2023;12(32):e2301687.","journal-title":"Adv Healthc Mater"},{"issue":"5","key":"3560_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/14760584.2021.1908133","volume":"20","author":"GH Lee","year":"2021","unstructured":"Lee GH, Lim SG. CpG-Adjuvanted hepatitis B vaccine (HEPLISAV-B\u00ae) update. Expert Rev Vaccines. 2021;20(5):487\u201395.","journal-title":"Expert Rev Vaccines"},{"issue":"1\u20132","key":"3560_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ijpharm.2014.03.015","volume":"466","author":"M Huang","year":"2014","unstructured":"Huang M, Wang W. Factors affecting alum-protein interactions. Int J Pharm. 2014;466(1\u20132):139\u201346.","journal-title":"Int J Pharm"},{"key":"3560_CR40","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jconrel.2020.10.066","volume":"330","author":"G Anderluzzi","year":"2021","unstructured":"Anderluzzi G, Schmidt ST, Cunliffe R, Woods S, Roberts CW, Veggi D, Ferlenghi I, O\u2019Hagan DT, Baudner BC, Perrie Y. Rational design of adjuvants for subunit vaccines: the format of cationic adjuvants affects the induction of antigen-specific antibody responses. J Control Release. 2021;330:933\u201344.","journal-title":"J Control Release"},{"issue":"12","key":"3560_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/nnano.2012.207","volume":"7","author":"MP Monopoli","year":"2012","unstructured":"Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular Coronas provide the biological identity of nanosized materials. Nat Nanotechnol. 2012;7(12):779\u201386.","journal-title":"Nat Nanotechnol"},{"issue":"2","key":"3560_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nnano.2012.237","volume":"8","author":"A Salvati","year":"2013","unstructured":"Salvati A, Pitek AS, Monopoli MP, Prapainop K, Bombelli FB, Hristov DR, Kelly PM, \u00c5berg C, Mahon E, Dawson KA. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule Corona adsorbs on the surface. Nat Nanotechnol. 2013;8(2):137\u201343.","journal-title":"Nat Nanotechnol"},{"issue":"7","key":"3560_CR43","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1039\/C1CS15233E","volume":"41","author":"CD Walkey","year":"2012","unstructured":"Walkey CD, Chan WC. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev. 2012;41(7):2780\u201399.","journal-title":"Chem Soc Rev"},{"issue":"4","key":"3560_CR44","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.coviro.2011.07.002","volume":"1","author":"T Aoshi","year":"2011","unstructured":"Aoshi T, Koyama S, Kobiyama K, Akira S, Ishii KJ. Innate and adaptive immune responses to viral infection and vaccination. Curr Opin Virol. 2011;1(4):226\u201332.","journal-title":"Curr Opin Virol"},{"issue":"4","key":"3560_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41571-024-00859-1","volume":"21","author":"I Heras-Murillo","year":"2024","unstructured":"Heras-Murillo I, Ad\u00e1n-Barrientos I, Gal\u00e1n M, Wculek SK, Sancho D. Dendritic cells as orchestrators of anticancer immunity and immunotherapy. Nat Rev Clin Oncol. 2024;21(4):257\u201377.","journal-title":"Nat Rev Clin Oncol"},{"key":"3560_CR46","doi-asserted-by":"publisher","first-page":"101481","DOI":"10.1016\/j.smim.2021.101481","volume":"52","author":"AE Marciscano","year":"2021","unstructured":"Marciscano AE, Anandasabapathy N. The role of dendritic cells in cancer and anti-tumor immunity. Semin Immunol. 2021;52:101481.","journal-title":"Semin Immunol"},{"issue":"5","key":"3560_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2019027047","volume":"36","author":"N Wang","year":"2019","unstructured":"Wang N, Qian R, Liu T, Wu T, Wang T. Nanoparticulate carriers used as vaccine adjuvant delivery systems. Crit Rev Ther Drug Carrier Syst. 2019;36(5):449\u201384.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"3","key":"3560_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1172\/JCI81083","volume":"126","author":"TJ Moyer","year":"2016","unstructured":"Moyer TJ, Zmolek AC, Irvine DJ. Beyond antigens and adjuvants: formulating future vaccines. J Clin Invest. 2016;126(3):799\u2013808.","journal-title":"J Clin Invest"},{"issue":"25","key":"3560_CR49","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","volume":"184","author":"C Cui","year":"2021","unstructured":"Cui C, Wang J, Fagerberg E, Chen PM, Connolly KA, Damo M, Cheung JF, Mao T, Askari AS, Chen S, Fitzgerald B, Foster GG, Eisenbarth SC, Zhao H, Craft J, Joshi NS. Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell. 2021;184(25):6101\u2013e611813.","journal-title":"Cell"},{"key":"3560_CR50","doi-asserted-by":"publisher","first-page":"102162","DOI":"10.1016\/j.cis.2020.102162","volume":"279","author":"S Shrestha","year":"2020","unstructured":"Shrestha S, Wang B, Dutta P. Nanoparticle processing: Understanding and controlling aggregation. Adv Colloid Interface Sci. 2020;279:102162.","journal-title":"Adv Colloid Interface Sci"},{"issue":"40","key":"3560_CR51","doi-asserted-by":"publisher","first-page":"e2004210","DOI":"10.1002\/adma.202004210","volume":"32","author":"S Peng","year":"2020","unstructured":"Peng S, Cao F, Xia Y, Gao XD, Dai L, Yan J, Ma G. Particulate alum via Pickering emulsion for an enhanced COVID-19 vaccine adjuvant. Adv Mater. 2020;32(40):e2004210.","journal-title":"Adv Mater"},{"issue":"24","key":"3560_CR52","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1016\/j.vaccine.2019.04.055","volume":"37","author":"S Shi","year":"2019","unstructured":"Shi S, Zhu H, Xia X, Liang Z, Ma X, Sun B. Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity. Vaccine. 2019;37(24):3167\u201378.","journal-title":"Vaccine"},{"issue":"4","key":"3560_CR53","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/apm.12143","volume":"122","author":"A Garc\u00eda","year":"2014","unstructured":"Garc\u00eda A, De Sanctis JB. An overview of adjuvant formulations and delivery systems. APMIS. 2014;122(4):257\u201367.","journal-title":"APMIS"},{"issue":"1","key":"3560_CR54","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41541-023-00734-7","volume":"8","author":"TJ Ruckwardt","year":"2023","unstructured":"Ruckwardt TJ. The road to approved vaccines for respiratory syncytial virus. NPJ Vaccines. 2023;8(1):138.","journal-title":"NPJ Vaccines"},{"issue":"1","key":"3560_CR55","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-025-56302-1","volume":"16","author":"M Lin","year":"2025","unstructured":"Lin M, Yin Y, Zhao X, Wang C, Zhu X, Zhan L, Chen L, Wang S, Lin X, Zhang J, Xia N, Zheng Z. A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus. Nat Commun. 2025;16(1):1386.","journal-title":"Nat Commun"},{"issue":"3","key":"3560_CR56","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1128\/CVI.00703-12","volume":"20","author":"K Timmermans","year":"2013","unstructured":"Timmermans K, Plantinga TS, Kox M, Vaneker M, Scheffer GJ, Adema GJ, Joosten LA, Netea MG. Blueprints of signaling interactions between pattern recognition receptors: implications for the design of vaccine adjuvants. Clin Vaccine Immunol. 2013;20(3):427\u201332.","journal-title":"Clin Vaccine Immunol"},{"key":"3560_CR57","doi-asserted-by":"publisher","first-page":"938598","DOI":"10.3389\/fimmu.2022.938598","volume":"13","author":"L Bian","year":"2022","unstructured":"Bian L, Zheng Y, Guo X, Li D, Zhou J, Jing L, Chen Y, Lu J, Zhang K, Jiang C, Zhang Y, Kong W. Intramuscular inoculation of AS02-Adjuvanted respiratory syncytial virus (RSV) F subunit vaccine shows better efficiency and safety than subcutaneous inoculation in balb\/c mice. Front Immunol. 2022;13:938598.","journal-title":"Front Immunol"},{"issue":"6","key":"3560_CR58","doi-asserted-by":"publisher","first-page":"1231003","DOI":"10.1142\/S0219720012310038","volume":"10","author":"W Li","year":"2012","unstructured":"Li W. Volcano plots in analyzing differential expressions with mRNA microarrays. J Bioinform Comput Biol. 2012;10(6):1231003.","journal-title":"J Bioinform Comput Biol"},{"issue":"2","key":"3560_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/jpm9020021","volume":"9","author":"C de Mar\u00edn","year":"2019","unstructured":"de Mar\u00edn C, Raplee ID, Lockhart J, Jaimes G, Evsikov AV. The transcriptomic toolbox: resources for interpreting large gene expression data within a precision medicine context for metabolic disease atherosclerosis. J Pers Med. 2019;9(2):21.","journal-title":"J Pers Med"},{"issue":"1","key":"3560_CR60","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13059-024-03361-0","volume":"25","author":"Y Hu","year":"2024","unstructured":"Hu Y, Xie M, Li Y, Rao M, Shen W, Luo C, Qin H, Baek J, Zhou XM. Benchmarking clustering, alignment, and integration methods for Spatial transcriptomics. Genome Biol. 2024;25(1):212.","journal-title":"Genome Biol"},{"key":"3560_CR61","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41590-024-02036-z","volume":"26","author":"M Cortese","year":"2025","unstructured":"Cortese M, Hagan T, Rouphael N, et al. System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans. Nat Immunol. 2025;26:116\u201330.","journal-title":"Nat Immunol"},{"issue":"22","key":"3560_CR62","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barber\u00e0 J, Vesikari T, Watanabe D, Weckx L, Zahaf T, Heineman TC, ZOE-50 Study Group. Efficacy of an adjuvanted herpes Zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087\u201396.","journal-title":"N Engl J Med"},{"issue":"5","key":"3560_CR63","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/vaccines11051003","volume":"11","author":"K Lin","year":"2023","unstructured":"Lin K, Cao H, Luan N, Wang Y, Hu J, Liu C. Comparison of the immune effects of an mRNA vaccine and a subunit vaccine against herpes Zoster administered by different injection methods. Vaccines (Basel). 2023;11(5):1003.","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"3560_CR64","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s40266-018-0603-x","volume":"35","author":"YY Syed","year":"2018","unstructured":"Syed YY. Recombinant Zoster vaccine (Shingrix\u00ae): A review in herpes Zoster. Drugs Aging. 2018;35(12):1031\u201340.","journal-title":"Drugs Aging"},{"key":"3560_CR65","doi-asserted-by":"publisher","first-page":"102172","DOI":"10.1016\/j.cbpa.2022.102172","volume":"70","author":"A Kaur","year":"2022","unstructured":"Kaur A, Baldwin J, Brar D, Salunke DB, Petrovsky N. Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics. Curr Opin Chem Biol. 2022;70:102172.","journal-title":"Curr Opin Chem Biol"},{"issue":"4","key":"3560_CR66","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/vaccines12040428","volume":"12","author":"S Alouini","year":"2024","unstructured":"Alouini S, Pichon C. Therapeutic vaccines for HPV-Associated cervical malignancies: A systematic review. Vaccines (Basel). 2024;12(4):428.","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"3560_CR67","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1586\/14760584.2015.966696","volume":"14","author":"KY Shen","year":"2015","unstructured":"Shen KY, Chang LS, Leng CH, Liu SJ. Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact. Expert Rev Vaccines. 2015;14(3):383\u201394.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"3560_CR68","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12951-021-01074-1","volume":"19","author":"W Cao","year":"2021","unstructured":"Cao W, Jin M, Yang K, Chen B, Xiong M, Li X, Cao G. Fenton\/Fenton-like metal-based nanomaterials combine with oxidase for synergistic tumor therapy. J Nanobiotechnol. 2021;19(1):325.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"3560_CR69","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1021\/acsnano.4c09525","volume":"19","author":"MR Chiang","year":"2025","unstructured":"Chiang MR, Hsu CW, Pan WC, Tran NT, Lee YS, Chiang WH, Liu YC, Chen YW, Chiou SH, Hu SH. Reprogramming dysfunctional dendritic cells by a versatile catalytic dual oxide Antigen-Captured nanosponge for remotely enhancing lung metastasis immunotherapy. ACS Nano. 2025;19(2):2117\u201335.","journal-title":"ACS Nano"},{"issue":"5","key":"3560_CR70","doi-asserted-by":"publisher","first-page":"e2406178","DOI":"10.1002\/smll.202406178","volume":"21","author":"BN Yalamandala","year":"2025","unstructured":"Yalamandala BN, Moorthy T, Liu ZH, Huynh TMH, Iao HM, Pan WC, Wang KL, Chiang CS, Chiang WH, Liao LD, Liu YC, Hu SH. A Self-Cascading catalytic therapy and antigen capture Scaffold-Mediated T cells augments for postoperative brain immunotherapy. Small. 2025;21(5):e2406178.","journal-title":"Small"},{"issue":"28","key":"3560_CR71","doi-asserted-by":"publisher","first-page":"18712","DOI":"10.1021\/acsnano.4c06183","volume":"18","author":"BN Yalamandala","year":"2024","unstructured":"Yalamandala BN, Chen YJ, Lin YH, Huynh TMH, Chiang WH, Chou TC, Liu HW, Huang CC, Lu YJ, Chiang CS, Chu LA, Hu SH. A Self-Cascade penetrating brain tumor immunotherapy mediated by Near-Infrared II cell Membrane-Disrupting nanoflakes via detained dendritic cells. ACS Nano. 2024;18(28):18712\u201328.","journal-title":"ACS Nano"},{"issue":"1","key":"3560_CR72","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/21645515.2016.1225635","volume":"13","author":"N Gar\u00e7on","year":"2017","unstructured":"Gar\u00e7on N, Di Pasquale A. From discovery to licensure, the adjuvant system story. Hum Vaccines Immunotherapeutics. 2017;13(1):19\u201333.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"33","key":"3560_CR73","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1016\/j.vaccine.2022.06.064","volume":"40","author":"G Badran","year":"2022","unstructured":"Badran G, Angrand L, Masson JD, Cr\u00e9peaux G, David MO. Physico-chemical properties of aluminum adjuvants in vaccines: implications for toxicological evaluation. Vaccine. 2022;40(33):4881\u20138.","journal-title":"Vaccine"},{"key":"3560_CR74","doi-asserted-by":"crossref","unstructured":"Boehm O. Zur, Berndt, Koch, Alexander, Tran, Nguyen, Freyenhagen, Rainer, Hartmann, Matthias and Zacharowski, Kai. Clinical chemistry reference database for Wistar rats and C57\/BL6 mice Biological Chemistry. 2007;388(5):547\u2013554.","DOI":"10.1515\/BC.2007.061"},{"issue":"29","key":"3560_CR75","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","volume":"30","author":"DT O\u2019Hagan","year":"2012","unstructured":"O\u2019Hagan DT, Ott GS, De Gregorio E, Seubert A. The mechanism of action of MF59-an innately attractive adjuvant formulation. Vaccine. 2012;30(29):4341\u20138.","journal-title":"Vaccine"},{"key":"3560_CR76","doi-asserted-by":"publisher","first-page":"627932","DOI":"10.3389\/fimmu.2021.627932","volume":"12","author":"SJ Paston","year":"2021","unstructured":"Paston SJ, Brentville VA, Symonds P, Durrant LG. Cancer vaccines, adjuvants, and delivery systems. Front Immunol. 2021;12:627932.","journal-title":"Front Immunol"},{"issue":"6","key":"3560_CR77","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1021\/ja3063293","volume":"135","author":"NO Fischer","year":"2013","unstructured":"Fischer NO, Rasley A, Corzett M, Hwang MH, Hoeprich PD, Blanchette CD. Colocalized delivery of adjuvant and antigen using Nanolipoprotein particles enhances the immune response to Recombinant antigens. J Am Chem Soc. 2013;135(6):2044\u20137.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"3560_CR78","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao T, Cai Y, Jiang Y, He X, Wei Y, Yu Y, Tian X. Vaccine adjuvants: mechanisms and platforms. Signal Transduct Target Ther. 2023;8(1):283.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"3560_CR79","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1021\/acsnano.0c08379","volume":"15","author":"YF Kang","year":"2021","unstructured":"Kang YF, Sun C, Zhuang Z, Yuan RY, Zheng Q, Li JP, Zhou PP, Chen XC, Liu Z, Zhang X, Yu XH, Kong XW, Zhu QY, Zhong Q, Xu M, Zhong NS, Zeng YX, Feng GK, Ke C, Zhao JC, Zeng MS. Rapid development of SARS-CoV-2 Spike protein Receptor-Binding domain Self-Assembled nanoparticle vaccine candidates. ACS Nano. 2021;15(2):2738\u201352.","journal-title":"ACS Nano"},{"key":"3560_CR80","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jconrel.2022.07.032","volume":"349","author":"Z Chen","year":"2022","unstructured":"Chen Z, Hao X, Wang H, Zhong X, Chen X, Zhao Y, Zhang Y, Du G, Sun X. Smart combination of aluminum hydroxide and MF59 to induce strong cellular immune responses. J Control Release. 2022;349:699\u2013711.","journal-title":"J Control Release"},{"key":"3560_CR81","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.2147\/IJN.S164097","volume":"13","author":"H Dong","year":"2018","unstructured":"Dong H, Wen ZF, Chen L, Zhou N, Liu H, Dong S, Hu HM, Mou Y. Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells. Int J Nanomed. 2018;13:3353\u201365.","journal-title":"Int J Nanomed"},{"issue":"2","key":"3560_CR82","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nm987","volume":"10","author":"M Heikenwalder","year":"2004","unstructured":"Heikenwalder M, Polymenidou M, Junt T, Sigurdson C, Wagner H, Akira S, Zinkernagel R, Aguzzi A. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med. 2004;10(2):187\u201392.","journal-title":"Nat Med"},{"key":"3560_CR83","first-page":"175","volume":"198","author":"CF Ware","year":"1995","unstructured":"Ware CF, VanArsdale TL, Crowe PD, Browning JL. The ligands and receptors of the lymphotoxin system. Curr Top Microbiol Immunol. 1995;198:175\u2013218.","journal-title":"Curr Top Microbiol Immunol"},{"key":"3560_CR84","doi-asserted-by":"publisher","first-page":"124799","DOI":"10.1016\/j.ijpharm.2024.124799","volume":"666","author":"K \u00d6zt\u00fcrk","year":"2024","unstructured":"\u00d6zt\u00fcrk K, Kaplan M, \u00c7al\u0131\u015f S. Effects of nanoparticle size, shape, and zeta potential on drug delivery. Int J Pharm. 2024;666:124799.","journal-title":"Int J Pharm"},{"issue":"18","key":"3560_CR85","doi-asserted-by":"publisher","first-page":"10887","DOI":"10.3390\/ijms231810887","volume":"23","author":"J Jie","year":"2022","unstructured":"Jie J, Liu G, Feng J, Huo D, Wu Y, Yuan H, Tai G, Ni W. MF59 promoted the combination of CpG ODN1826 and MUC1-MBP Vaccine-Induced antitumor activity involved in the enhancement of DC maturation by prolonging the local retention time of antigen and Down-Regulating of IL-6\/STAT3. Int J Mol Sci. 2022;23(18):10887.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"3560_CR86","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/smll.201300012","volume":"9","author":"D Mahony","year":"2013","unstructured":"Mahony D, Cavallaro AS, Stahr F, Mahony TJ, Qiao SZ, Mitter N. Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice. Small. 2013;9(18):3138\u201346.","journal-title":"Small"},{"issue":"1","key":"3560_CR87","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1038\/s41467-023-38066-8","volume":"14","author":"H Lei","year":"2023","unstructured":"Lei H, Alu A, Yang J, He X, He C, Ren W, Chen Z, Hong W, Chen L, He X, Yang L, Li J, Wang Z, Wang W, Wei Y, Lu S, Lu G, Song X, Wei X. Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants. Nat Commun. 2023;14(1):2678.","journal-title":"Nat Commun"},{"issue":"710","key":"3560_CR88","doi-asserted-by":"publisher","first-page":"eadg6050","DOI":"10.1126\/scitranslmed.adg6050","volume":"15","author":"L Sacconnay","year":"2023","unstructured":"Sacconnay L, De Smedt J, Rocha-Perugini V, Ong E, Mascolo R, Atas A, Vanden Abeele C, de Heusch M, De Schrevel N, David MP, Bouzya B, Stobbelaar K, Vanloubbeeck Y, Delputte PL, Mallett CP, Dezutter N, Warter L. The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains. Sci Transl Med. 2023;15(710):eadg6050.","journal-title":"Sci Transl Med"},{"issue":"1","key":"3560_CR89","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13027-021-00346-7","volume":"16","author":"F Dorostkar","year":"2021","unstructured":"Dorostkar F, Arashkia A, Roohvand F, Shoja Z, Navari M, Mashhadi Abolghasem Shirazi M, Shahosseini Z, Farahmand M, Shams Nosrati MS, Jalilvand S. Co-administration of 2\u20193\u2019-cGAMP STING activator and CpG-C adjuvants with a mutated form of HPV 16 E7 protein leads to tumor growth Inhibition in the mouse model. Infect Agent Cancer. 2021;16(1):7.","journal-title":"Infect Agent Cancer"},{"issue":"686","key":"3560_CR90","doi-asserted-by":"publisher","first-page":"eabn3464","DOI":"10.1126\/scitranslmed.abn3464","volume":"15","author":"J Ramos da Silva","year":"2023","unstructured":"Ramos da Silva J, Bitencourt Rodrigues K, Formoso Pelegrin G, Silva Sales N, Muramatsu H, de Oliveira Silva M, Porchia BFMM, Moreno ACR, Aps LRMM, Venceslau-Carvalho AA, Tomb\u00e1cz I, Fotoran WL, Karik\u00f3 K, Lin PJC, Tam YK, de Oliveira Diniz M, Pardi N, de Souza Ferreira LC. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice. Sci Transl Med. 2023;15(686):eabn3464.","journal-title":"Sci Transl Med"},{"issue":"1","key":"3560_CR91","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2015.11.029","volume":"373","author":"M Jordan","year":"2016","unstructured":"Jordan M, Waxman DJ. CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model. Cancer Lett. 2016;373(1):88\u201396.","journal-title":"Cancer Lett"},{"issue":"41","key":"3560_CR92","doi-asserted-by":"publisher","first-page":"e2402678","DOI":"10.1002\/advs.202402678","volume":"11","author":"Z Liu","year":"2024","unstructured":"Liu Z, Li S, Xiao Y, Liu X, Zhang B, Zeng Q, Ao Q, Zhang X. A Multi-Functional nanoadjuvant coupling manganese with Toll-Like 9 agonist stimulates potent innate and adaptive Anti-Tumor immunity. Adv Sci (Weinh). 2024;11(41):e2402678.","journal-title":"Adv Sci (Weinh)"},{"key":"3560_CR93","doi-asserted-by":"crossref","unstructured":"Muzellec B, Tele\u0144czuk M, Cabeli V, Andreux M. PyDESeq2: a python package for bulk RNA-seq differential expression analysis. Bioinformatics. 2023;39(9).","DOI":"10.1093\/bioinformatics\/btad547"},{"issue":"60","key":"3560_CR94","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"M Waskom","year":"2021","unstructured":"Waskom M. Seaborn: statistical data visualization. J Open Source Softw. 2021;6(60):3021.","journal-title":"J Open Source Softw"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03560-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03560-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03560-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:04:20Z","timestamp":1751364260000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03560-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3560"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03560-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted under the Regional Ethics Committee for Animal Experiments at Xiamen University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"472"}}